Sarcomatoid Carcinoma in a Resected Hepatic Metastasis of Esophageal Squamous Cell Carcinoma after Chemotherapy
Kotaro Kimura(Teine Keijinkai Hospital), Yuko Omori(Hokkaido University), Noriaki Kyogoku(Teine Keijinkai Hospital), Yusuke Tsunetoshi(Teine Keijinkai Hospital), Yoshiyasu Ambo(Hokkaido University of Science), Chiho Goto(Nagoya Bunri University), Naoya Okada, Hirokatsu Katagiri(Iwate Medical University), Tomohiro Suzuki(Tokyo Future University), Yusuke Asai, Zenya Naito(Hokkaido University), Takumi Yamabuki(Teine Keijinkai Hospital), Ryo Koyama(Japan Proton Accelerator Research Complex), Hiroyuki Yamamoto(Teine Keijinkai Hospital), Yoshihiro Kinoshita(Teine Keijinkai Hospital), Minoru Takada(Kindai University Hospital), Saki Kawaguchi(Teine Keijinkai Hospital), Kentaro Kato(Hokkaido University)
Cited by 0
Related Papers
Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab
|Science Translational Medicine|2011|670
Randomized clinical trial of adjuvant gemcitabine chemotherapy <i>versus</i> observation in resected bile duct cancer
|British journal of surgery|2018|401
Distal Pancreatectomy With En Bloc Celiac Axis Resection for Locally Advanced Pancreatic Body Cancer
|Annals of Surgery|2007|315